Track topics on Twitter Track topics that are important to you
Latokartanonkaari 11 D-talo
Phone: 358- 9- 3478 900
Fax: 358-9- 3478 9090
Pittsburgh, June 05, 2018 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., a clinical stage neuroscience company focused on the development of innovative therapeutics for the treatment of Alzheime...
Publication Details Discovery of 3-Sulfopropanoic Acid, the Primary Metabolite of Tramiprosate and its Prodrug ALZ-801, in Cerebrospinal Fluid of Healthy Subjects as well as Alzhe...
The formation of amyloid-β peptide (Aβ) oligomers at the cellular membrane is considered a crucial process that underlies neurotoxicity in Alzheimer's disease (AD). To obtain structural information ...
The effects of oligomer length, solvent, and temperature on the self-association of stably folded short aromatic oligoamide are probed. With large flat surfaces, these aromatic oligoamides undergo sta...
A study of reaction kinetics and removal efficiency of a family of ruthenium (Ru)-based olefin metathesis catalysts containing ethylene-glycol-oligomer-tethered N-heterocyclic carbene (NHC) ligands ha...
We demonstrate that DFT-based calculations can provide straightforward means to analyze the effect of aggregation on the optical properties of regioregular P3HT oligomers of different lengths (up to 2...
In this work, a simple hydrothermal method was developed to synthesize CuO plates in centimeter scale for the first time. Plates of up to 20 μm thickness and several square millimeters in area have b...
This is a multi‐center, Phase 1b, randomized, double‐blind, placebo‐controlled parallel‐group trial in adults with mild to moderate AD.
AVI-4020 Injection, a phosphorodiamidate Morpholino oligomer (PMO), was found to cross the blood-brain barrier during a study of patients with presumptive West Nile virus disease. AVI-4065...
Duchenne muscular dystrophy (DMD), a fatal muscle degenerative disorder, arises from mutations in the dystrophin gene. Antisense therapy with the use of antisense oligonucleotides (AON) ha...
Bio-Synthesis Inc was the first commercial company providing DNA and peptides in 1984. We specialize in custom peptide synthesis from small to large scale and we can help you design the optimal pepti...
PolyMedix is the leader in developing biomimetics - novel small molecule, oligomer and polymer protein-mimetic drugs for membrane protein and protein:protein targets. PolyMedix has a proven computatio...
Established in 1990, BioChrom Labs, Inc., Indiana, USA, is dedicated to developing and manufacturing polymeric materials using patentable and proprietary technologies. HYDROCELL HPLC Columns and packi...
Innovative RNA-Based Technology; First-in-Class Therapeutics Sarepta Therapeutics – formerly AVI BioPharma – remains focused on developing first-in-class, RNA-based therapeutics to imp...
We have published hundreds of Oligomer Oy news stories on BioPortfolio along with dozens of Oligomer Oy Clinical Trials and PubMed Articles about Oligomer Oy for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Oligomer Oy Companies in our database. You can also find out about relevant Oligomer Oy Drugs and Medications on this site too.